Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial

Fig. 2

Progression-free survival (PFS) and overall survival (OS) by circulating tumor cell (CTC) count. Kaplan-Meier curves displaying PFS and OS by baseline (BL) CTC count (≥ 5 CTCs) (a-b), by CTC count at BL and 1 month (c-d), by CTC count at BL and 3 months (e-f) and by CTC count at BL and 6 months (g-h) during the first 6 months of systemic therapy for MBC. Analyses at 1, 3, and 6 months were performed using landmark analysis, in which the follow-up time was recalculated with a new starting date from the 1, 3, and 6-month sample, respectively

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us